Plastic-derived edible products approved for consumption by the end of 2025? Yes: real money —, play money 5% No: real money —, play money 95% Volume: real money 34.030245, play money 14390.85 Bettors: real money 0, play money 39 Categories: Science, Bioengineering Related markets Orion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027? (ID: 188268) Volume: real 229.73788695, play 28306.36245623 Bettors: real 8, play 42 Leading (real money): Orion (a device that promises to project artificial vision into the brains of blind people) approved 29% Leading (play money): Orion (a device that promises to project artificial vision into the brains of blind people) approved 16% Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? (ID: 209055) Volume: real 99.75069955, play 29620.78326599 Bettors: real 6, play 13 Leading (real money): Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? 9% Leading (play money): Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? 2%

Plastic-derived edible products approved for consumption by the end of 2025?

Market Rules

In 2021, researchers at the University of Illinois and Michigan Technological University (USA) created a technology capable of converting plastic waste into edible protein. The innovation promises to generate a safe, affordable and sustainable source of food while reducing the environmental damage associated with plastic waste and traditional agricultural methods.

The technology is based on bioengineering, where genes were inserted into bacteria that made them capable of breaking down molecules from plastic residues and turning them into a category of organic material that could be ingested by humans. Nonetheless, more studies are needed to investigate the safety of consuming this material.

If any plastic-derived edible product is approved for human consumption as food by the end of 2025, by the national health regulation agency from at least one of the following territories (USA, European Union, United Kingdom, Russia, Brazil, China or Japan), this market will be resolved as “yes”.

Related Markets